Cell Medica Appoints New CEOCell Medica, a company active in the development, manufacture and marketing of personalised cellular immunotherapeutics for the treatment of cancer, has appointed Chris Nowers as Chief Executive Officer … more ➔
Marinomed Biotech Appoints New CFOPascal Schmidt appointed CFO as Vienna based biotech firm Marinomedas of August 1 2018. more ➔
Morphosys launches US subsidiary, appoints...Morphosys has named Jennifer Herron President of MorphoSys US Inc. to build up sales presence overseas. more ➔
Lundbeck names new president and CEOThe Board of Directors of the company has appointed Dr. Deborah Dunsire as new president and CEO of Lundbeck. Deborah Dunsire will take up her new position on 1 September 2018. more ➔
Corbion CEO de Ruiter named new EuropaBio...EuropaBio’s Executive Board and General Assembly of Members this week confirmed the appointment of Tjerk de Ruiter as Chairman of the association. more ➔
Symcel appoints two new board membersSymcel has announced the appointment of two new board members; Erik Walldén and Stefan Löfås. Both will play a key role in the company’s corporate strategy to grow business in the research market … more ➔
Dave Lemus joins Silence Therapeutics Boar...Silence Therapeutics plc, a company active in the development of RNA therapeutics, has announced the appointment of Dave Lemus to its Board as Non-Executive Director. more ➔
Abivax Appoints Ian McGowanAbivax, a biotechnology company working to develop a functional cure for HIV as well as treatments for inflammatory/autoimmune diseases and cancer, appoints Ian McGowan as Scientific Advisory Board Chair … more ➔
New DirectorT cell therapy developer Crescendo Biologics Ltd (Crescendo) has named Eva-Lotta Allan Non-Executive Director of the company. The former CFO of Immunocore brings in over 30 years’ experience in the biopharmaceutical … more ➔
Dirk Kersten joins Forbion as General Part...Forbion, a European life science venture capital firm, today announces that Dirk Kersten will join as a General Partner on October 1st, 2018. more ➔
